Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: Increased expression results in isoniazid resistance

Journal of Bacteriology

Volumn 181, Issue 4, 1999, Pages 1343-1347

  Payton, Mark ^a   Auty, Roy ^a   Delgoda, Rupika ^a   Everett, Martin ^b   Edith, Sim ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ISONIAZID; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG ACETYLATION; DRUG INACTIVATION; ENZYME ACTIVITY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; GENE OVEREXPRESSION; GENETIC CONSERVATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT GENE; SALMONELLA TYPHIMURIUM; SEQUENCE ANALYSIS;

EID: 0033019777     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.181.4.1343-1347.1999     Document Type: Article

References (34)

1. Blattner, F., G. Plunkett, C. Bloch, N. Perna, V. Burland, M. Riley, J. Collado-Vides, J. Glasner, C. Rode, G. Mayhew, J. Gregor, N. Davis, H. Kirkpatrick, M. Goeden, D. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K12. Science 277:1453-1474.
2. Blum, M., D. M. Grant, W. McBride, M. Heim, and U. A. Meyer. 1990. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 9:193-203.
3. Cole, S. T., R. Brosch, J. Parkhill, T. Gamier, C. Churcher, D. Harris, and B. Barrel. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
4. Cribb, A. E., H. Nakamura, D. M. Grant, M. A. Miller, and S. P. Spielberg. 1993. Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism. Biochem. Pharmacol. 45:1277-1282.
5. Deguchi, T. 1992. Physiology and molecular biology of arylamine N-acetyltransferases. Biomed. Res. 13:231-242.
6. Delomenie, C., G. H. Goodfellow, R. Krishnamoorthy, D. M. Grant, and J. M. Dupret. 1997. Study of the role of the highly conserved residues Arg(9) and Arg(64) in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis. Biochem. J. 323:207-215.
7. Dhandayuthapani, S., Y. Zhang, M. H. Mudd, and V. Deretic. 1996. Oxidadtive stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. J. Bacteriol. 178:3641-3649.
8. Ellard, G. A., and P. T. Gammon. 1976. Pharmacokenetics of isoniazid metabolism in man. J. Pharmacokinet. Biopharm. 4:83-113.
9. Evans, D. A. P., K. A. Manley, and V. A. McKuisick. 1960. Genetic control of isoniazid acetylation in man. Br. Med. J. 2:485-491.
10. Hein, D. W., M. A. Doll, K. Gray, T. D. Rustan, and R. J. Ferguson. 1993. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res. 53:509-514.
11. Heym, B., Y. Zhang, S. Poulet, D. Young, and S. T. Cole. 1993. Characterization of the katG gene encoding catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J. Bacteriol. 175:4255-4259.
12. Hubbard, T., A. Tramontano, and I. W. Team. 1996. Update on protein structure prediction: results of the 1995 IRBM Workshop. Protein Folding Design 1:R55-R63.
13. Jehne, J. W. 1965. Partial purification and properties of the isoniazid transacetylase in human liver: its relationship to the acetylation of p-aminosalicylic acid. J. Clin. Investig. 44:1992-2002.
14. Kruger-Thiemer, E. 1958. Isonicotinic acid hypothesis of the anti-tuberculosis action of isoniazid. Am. Rev. Tuberc. 78:364-367.
15. Lévy-Frébault, V. V., and F. Portaels. 1992. Proposed minimum standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int. J. Syst. Bacteriol. 42:315-323.
16. Minchin, R. F. 1995. Acetylation of para-aminobenzoylglutamate, a folate catabolite, by recombinant human NAT and U937 cells. Biochem. J. 307:1-3.
17. Musser, M., V. Kapur, D. Williams, B. Kreiswirth, D. van Soolingen, and J. Van Embden. 1996. Characterisation of the catalase-peroxidase gene (katG) and inhA locus in isoniazid resistant and susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
18. Ohsako, S., and T. Deguchi. 1990. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases of human liver. J. Biol. Chem. 265:4630-4634.
19. Olson, W., P. Dayton, Z. Israili, and A. Pruitt. 1977. Spectrophotofluorimetric assay for isoniazid and acetylisoniazid in plasma adapted to paediatric studies. Clin. Chem. 23/24:745-748.
20. Palamanda, J., D. Hickman, A. Ward, E. Sim, M. Romkes-Sparks, and J. Unadkat. 1995. Dapsone acetylation by human liver N-acetyltransferase and interaction with anti-opportunistic infection drugs. Drug Metab. Dispos. 23:473-477.
21. Parish, T., E. Mahenthiralingam, P. Draper, E. O. Davis, and M. J. Colston. 1997. Regulation of the inducible amidase gene of Mycobacterium smegmatis. Microbiology 143:2267-2276.
22. Risch, A., V. Smelt, D. Lane, L. Stanely, W. van der Slot, A. Ward, and E. Sim. 1996. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients. Pharmacol. Toxicol. 78:235-240.
23. Rozwarski, D. A., G. A. Grant, D. H. R. Barton, W. R. Jacobs, and J. C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279:98-102.
24. Sinclair, J., R. Delgoda, M. Noble, S. Jarmin, N. Goh, and E. Sim. 1998. Purification, characterisation and crystallisation of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium. Prot. Expr. Purif. 12: 371-380.
25. Sinclair, J., and E. Sim. 1997. A fragment consisting of the first 204 aminoterminal amino acids of human arylamine N-acetyl transferase one (NAT1) and the first transacetylation step of catalysis. Biochem. Pharmacol. 53:11-16.
26. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs. 1990. Isolation and characterisation of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919.
27. Stanley, L., I. Mills, and E. Sim. 1997. Localisation of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. Pharmacogenetics 7:121-130.
28. Vatsis, K. P., W. W. Weber, D. A. Bell, J. M. Dupret, D. A. Evans, D. M. Grant, D. W. Hein, H. J. Lin, U. A. Meyer, M. V. Relling, et al. 1995. Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1-17.
29. Victor, T. C., R. Warren, J. L. Butt, A. M. Jordaan, J. V. Felix, A. Venter, F. A. Sirgel, H. S. Schaaf, P. R. Donald, M. Richardson, M. H. Cynamon, and P. D. VanHelden. 1997. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. J. Med. Microbiol. 46:847-857.
30. Ward, A., D. Hickman, J. W. Gordon, and E. Sim. 1992. Arylamine N-acetyltransferase in human red blood cells. Biochem. Pharmacol. 44:1099-1104.
31. Ward, A., M. Summers, and E. Sim. 1995. Purification of recombinant human NAT1 expressed in E. coli. Biochem. Pharm. 49:1759-1767.
32. Watanabe, M., T. Sofuni, and T. Nohmi. 1992. Involvement of Cys69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium. Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms. J. Biol. Chem. 267:8429-8436.
33. Weber, W. W., and D. W. Hein. 1985. Arylamine N-acetyltransferases. Pharmacol. Rev. 37:25-79.
34. Weber, W. W., and K. P. Vatsis. 1993. Individual variability in p-aminobenzoic acid acetylation by human N-acetyltransferase (NAT1) of peripheral blood. Pharmacogenetics 3:209-212.